Morgan Stanley’s TearLab Corporation TEAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,701
| Closed | -$2K | – | 6868 |
|
|
2017
Q3 | $2K | Hold |
1,701
| – | – | ﹤0.01% | 6422 |
|
|
2017
Q2 | $3K | Hold |
1,701
| – | – | ﹤0.01% | 6438 |
|
|
2017
Q1 | $5K | Hold |
1,701
| – | – | ﹤0.01% | 6377 |
|
|
2016
Q4 | $9K | Buy |
1,701
+941
| +124% | +$5.35K | ﹤0.01% | 6189 |
|
|
2016
Q3 | $5K | Hold |
760
| – | – | ﹤0.01% | 6258 |
|
|
2016
Q2 | $5K | Buy |
760
+40
| +6% | +$293 | ﹤0.01% | 6240 |
|
|
2016
Q1 | $4K | Hold |
720
| – | – | ﹤0.01% | 6344 |
|
|
2015
Q4 | $10K | Sell |
720
-183
| -20% | -$3.14K | ﹤0.01% | 6252 |
|
|
2015
Q3 | $18K | Buy |
903
+355
| +65% | +$8.31K | ﹤0.01% | 6082 |
|
|
2015
Q2 | $11K | Sell |
548
-300
| -35% | -$7.04K | ﹤0.01% | 6289 |
|
|
2015
Q1 | $17K | Sell |
848
-1,053
| -55% | -$25.3K | ﹤0.01% | 6107 |
|
|
2014
Q4 | $51K | Sell |
1,901
-657
| -26% | -$18.1K | ﹤0.01% | 5816 |
|
|
2014
Q3 | $87K | Sell |
2,558
-4,352
| -63% | -$184K | ﹤0.01% | 5535 |
|
|
2014
Q2 | $337K | Buy |
6,910
+6,151
| +810% | +$300K | ﹤0.01% | 4873 |
|
|
2014
Q1 | $51K | Buy |
759
+15
| +2% | +$1.15K | ﹤0.01% | 5705 |
|
|
2013
Q4 | $70K | Buy |
+744
| New | +$74.2K | ﹤0.01% | 5483 |
|
|
2013
Q3 | – | Sell |
-3,517
| Closed | -$373K | – | 5455 |
|
|
2013
Q2 | $373K | Buy |
+3,517
| New | +$322K | ﹤0.01% | 4470 |
|
Other funds holding TEAR
Morgan Stanley's TEAR Position: Q4 2017 in Review
Morgan Stanley sold out of TearLab Corporation (TEAR) in Q4 2017, closing a stake of 1,701 shares — an estimated $2K sold.
Morgan Stanley first reported a position in TEAR in Q2 2013 and held it in 17 quarters. The position peaked at $373K in Q2 2013. 3 funds tracked by Wall St. Rank hold TEAR as of Q4 2017.
- Morgan Stanley reported no remaining TearLab Corporation position as of Q4 2017 after selling out during the quarter.
- Morgan Stanley sold 1,701 TearLab Corporation shares in Q4 2017, an estimated $2K.
- Morgan Stanley first reported a position in TearLab Corporation in Q2 2013 and held it in 17 quarters.
- Morgan Stanley's TearLab Corporation position peaked at $373K in Q2 2013.
- 3 funds tracked by Wall St. Rank held TearLab Corporation as of Q4 2017.
Based on Morgan Stanley's 13F filing for Q4 2017, filed 14 Feb 2018.